Tag Archives: COVID-19

Hydroxychloroquine (HCQ) Update for 04/08/20

Hydroxychloroquine (HCQ) Update for 04/08/20 As you might expect, Natalie and I are receiving requests for prescriptions for HCQ. We’re refusing, based on the side-effect profile (especially for heart or kidney disease patients) and the lack of reliable data. And that doesn’t mean a randomized, double-blind, placebo controlled study. I’d go with the real-time experience […]